should we change how we position biologics for use in crohn’s disease?
Published 9 years ago • 2.1K plays • Length 21:02Download video MP4
Download video MP3
Similar videos
-
22:55
should we change how we position biologics for use in ulcerative colitis?
-
16:46
how will evolving future therapies change how we position biologics for use in ibd
-
12:58
positioning of biologics and new therapeutics for crohn's disease
-
21:14
when and how to use immunomodulators and biologics in ibd
-
20:08
biologics and mucosal healing in crohn’s disease: available evidence
-
5:57
tedxeast - ari meisel beats crohn's disease
-
3:27
living with ulcerative colitis – nour’s story
-
5:27
more about stool transplants (part 2) | dr reuben wong, gastroenterologist
-
18:03
understanding the contraindications to the use of immunomodulators and biologics for ibd
-
21:04
positioning of biologics in the clinic
-
17:51
personalizing care in crohn’s disease management
-
21:12
positioning immunomodulators as monotherapies or in combination with biologics
-
21:36
how will future therapeutic pathways change for ulcerative colitis and crohn's disease?
-
44:08
the evolution of personalized ibd care: navigating mechanisms of biologic therapies
-
1:12
biologic medications for ibd
-
1:12
how biologics for crohn's disease work | 3d medical animation | pixeldust studios
-
22:55
how should we position newer biologics in our current therapeutic algorithms?
-
17:44
implementing treatment pathways for the management of ulcerative colitis and crohn's disease
-
23:44
mechanisms of disease: biologic pipeline for ibd
-
12:13
positioning of biologics and new therapeutics for ulcerative colitis
-
21:01
transitional care in ibd: who is it for, and how should we do this?
-
26:25
understanding non-response and loss of response in ibd: which is it and when do we change classes?